HomecollectionsWebinarsDetect Biomarkers at Levels Previously Undetectable

SMC™ Technology: Detect Biomarkers at Levels Previously Undetectable


What Does It Cover?

Single molecule counting (SMC™) technology enables accurate measurement of molecules at levels previously undetectable allowing researchers to identify new biomarkers, or assist in therapeutic development with an improved view of efficacy, safety & time course studies. Combining a traditional immunoassay workflow with patented SMC™ technology enables the detection of low-abundance biomarkers, such as proteins and nucleic acids, with unparalleled sensitivity and accuracy, capturing concentrations down to the femtogram/mL level. You will learn how to detect, and monitor changes in, extremely low levels of established disease biomarkers such as cardiac troponin I and cytokines.

What Will You Learn?

  • General background on Single Molecule Counting (SMC™) technology
  • How SMC™ technology enables quantification of low concentration biomarkers for improved stratification of sample populations, drug development and new biomarker discovery
  • How to build your own bead-based or plate-based

Who Should Attend?

  • Researchers interested in biomarker discovery
  • Therapeutic development scientists
  • Protein biochemists
  • Life science researchers
  • Molecular biologists


Anitaben Tailor, Ph.D


SMC™ Technology and Advanced Application Lead

Anitaben Tailor earned her MSc in pharmacology from King’s College London and her Ph.D. in biochemical pharmacology from Queen Mary University of London. Prior to joining MilliporeSigma, she worked as a Field Application Scientist for Singulex for 5 years, where she provided Scientific support to Pharma and CRO’s on the SMC™ Technology. She then joined MilliporeSigma in July 2015, and in 2016 was appointed the role of SMC™ Technology and Application Advancement Lead. She is responsible developing novel applications utilizing the on the SMC™ Technology for diverse research areas.